CannaPharmaRX, Inc. (CPMD)

Market Cap	1.40M -39.0%
Revenue (ttm)	1.70M +24.8%
Net Income	-11.32M
EPS	-0.02
Shares Out	700.58M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,800
Open	0.0017
Previous Close	0.0020
Day's Range	0.0017 - 0.0020
52-Week Range	0.0003 - 0.0100
Beta	-1,603.56
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 19, 2026

About CannaPharmaRX

CannaPharmaRX, Inc. engages in acquisition, development, and operation of cannabis cultivation facilities in Germany, Israel, Portugal, and Canada. It produces and sells dried cannabis flower and trim shake, as well as unique genetics, medical cannabis, and craft products. The company is based in Cremona, Canada.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Constantine Nkafu
• Employees: 26
• Stock Exchange: OTCMKTS
• Ticker Symbol: CPMD

Financial Performance

In 2025, CannaPharmaRX's revenue was $1.36 million, an increase of 66.09% compared to the previous year's $820,137. Losses were -$11.13 million, 12.4% more than in 2024.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 18, 2026

Data Sources Report a data error